Competitive Intelligence, Diseases 0 Comments

Summarized clinical trials landscape for colorectal cancer as on 27th dec 2016. Data source: clinicaltrials.gov Clinical trials intelligenceBy: TrialsFind PRO Colorectal cancer clinical trials overview 1166 open studies for Colorectal cancer. 12% of trials are in phase 1. 27% of trials are in phase 2. 14% of trials are in phase 3. 2% of trials

Read More

Competitive Intelligence, Diseases 0 Comments

Summarized clinical trials landscape for non-small cell lung cancer as of 26th dec 2016. Data source: clinicaltrials.gov Clinical trials intelligence By: TrialsFind PRO NSCLC clinical trials overview Of the 15257 open cancer studies on clinicaltrials.gov, 988 (6.5%) are studies for NSCLC. Merck, Novartis and Astrazeneca are the most active industry players in NSCLC. 19% of

Read More

Companies 0 Comments

Medical tests are essential , but they come at an astounding cost. Typically, usual pharmaceutical firms tend to spend between 100 to 800 Billion Dollars for every medicine applicants. With all this, medication organizations seek the cost reducing methods to minimize the clinical trial costs. Of course, pharmaceutical organizations pull in a lot of money

Patients 0 Comments

Clinical trials are a platform that takes up drugs, new medicines and devices from their idea stage to being available in the open market. Thousands of trials are underway almost every day across the world. They have helped to introduce numerous effective treatment methods and instruments and changed the history of medicines.